Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.1 USD | +1.73% | -13.66% | +83.85% |
Chart calendar Catalyst Biosciences
Upcoming events on Catalyst Biosciences
No events available
Past events on Catalyst Biosciences
2023-03-08 | Q4 2022 Earnings Release (Projected) |
2023-01-12 | Ex-dividend day |
2022-12-27 08:00 | Catalyst Biosciences Inc and GNI Group Ltd Merger Call |
2022-09-20 | Ex-dividend day |
2022-08-15 16:05 | Interim 2022 Earnings Release |
2022-08-15 11:00 | Annual General Meeting |
2022-05-09 08:30 | Q1 2022 Earnings Release |
2022-03-31 08:00 | FY 2021 Earnings Release |
2022-01-04 | LifeSci Partners Corporate Access Event |
2021-11-18 13:54 | Piper Sandler Virtual Healthcare Conference |
2021-11-12 08:30 | Q3 2021 Earnings Call |
2021-11-12 07:00 | Q3 2021 Earnings Release |
2021-10-27 | American Society for Biochemistry and Molecular Biology Meeting |
2021-10-25 | Complement based Drug Development Summit |
2021-09-29 10:00 | Cantor Fitzgerald Global Healthcare Conference |
2021-09-15 13:00 | Investor Meeting - Fireside Chat |
2021-08-05 08:00 | Interim 2021 Earnings Release |
2021-07-19 12:00 | R&D Day |
2021-07-18 | International Society on Thrombosis and Haemostatis Virtual Congress - Subcutaneous Marzeptacog Alfa |
2021-07-18 | International Society on Thrombosis and Haemostatis Virtual Congress - Dose Selection of Marzeptacog |
Past dividends on Catalyst Biosciences
2023-01-12 | 0.24 USD |
2022-09-20 | 1.43 USD |
Annual results
Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,01 0,30 -98% | 0,00 0,00 - | 20,9 19,0 10.25% | 7,34 5,15 42.54% | 0,79 0,79 0% |
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
EBIT Million USD | Released Forecast Spread | -33,8 -32,8 -3.12% | -57,3 -58,1 1.42% | -57,4 -58,9 2.6% | -87,9 -89,0 1.26% | -30,4 -29,7 -2.33% |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 0,00 - | -55,2 -55,6 0.76% | -56,2 -57,9 2.87% | -87,9 -89,0 1.25% | -7,89 28,2 -128% |
Net income Million USD | Released Forecast Spread | -30,1 -29,8 -0.86% | -55,2 -56,3 1.99% | -56,2 -57,9 2.87% | -87,9 -89,0 1.25% | -8,24 28,2 -129.23% |
EPS USD | Released Forecast Spread | -40,2 -39,9 -0.75% | -69,0 -68,0 -1.47% | -43,9 -40,0 -9.88% | -43,0 -42,8 -0.47% | -3,90 13,5 -128.89% |
Announcement Date | 07/03/19 | 20/02/20 | 04/03/21 | 31/03/22 | 30/03/23 |
Quarterly results
Fiscal Period | December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 |
---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 2,30 0,50 359.8% | 2,44 0,25 876% | 0,79 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
EBIT Million USD | Released Forecast Spread | -25,2 -20,6 -22.36% | -20,3 -21,4 5.25% | -14,7 -15,6 5.96% | -5,72 -6,91 17.25% | -5,17 -3,25 -58.86% | -4,83 -4,13 -16.74% | 0,18 -2,68 106.65% | -2,54 -2,54 0.04% | -1,62 -2,08 22.05% |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -25,2 -20,6 -22.36% | -20,3 -21,4 5.19% | -14,5 -15,1 3.65% | 51,6 -6,82 857.18% | -4,88 -3,06 -59.4% | -40,1 -4,02 -898.41% | 0,27 -2,51 110.9% | -2,47 -2,48 0.52% | -1,58 -2,03 22.36% |
Net income Million USD | Released Forecast Spread | -25,2 -20,6 -22.36% | -20,3 -21,4 5.19% | -14,5 -15,1 3.65% | 51,6 -6,82 857.18% | -4,88 -3,06 -59.4% | -40,5 | 0,26 -2,51 110.34% | -2,47 -2,48 0.44% | -1,58 -2,03 22.36% |
EPS USD | Released Forecast Spread | -12,0 -9,95 -20.6% | -9,75 -9,55 -2.09% | -6,90 -6,60 -4.55% | 24,6 -3,30 845.45% | -2,40 -1,50 -60% | -19,2 | 0,15 -1,05 114.29% | -1,05 -1,05 0% | -0,60 -0,75 20% |
Announcement Date | 12/11/21 | 31/03/22 | 09/05/22 | 15/08/22 | 14/11/22 | 30/03/23 | 15/05/23 | 14/08/23 | 26/10/23 |
Past sector events for Catalyst Biosciences
- Stock Market
- Equities
- CBIO Stock
- Calendar Catalyst Biosciences